However, further investigation is required to determine how the pathological tau-mediated reduction in AP firing and previously reported impairments in synaptic activity are linked, an important step in understanding how pathological tau causes the cognitive decline observed in AD. The gene discussed is MAPT; the disease is Alzheimer disease.